首页 > 最新文献

EUROPEAN JOURNAL OF HEALTH LAW最新文献

英文 中文
De Jure and De Facto: An Overview on the Italian Measures on Compulsory Vaccination. De Jure和De Facto:意大利强制疫苗接种措施综述。
IF 0.8 Q2 LAW Pub Date : 2022-03-01 DOI: 10.1163/15718093-bja10067
Sofia Palmieri, T. Goffin
The outbreak of the Covid-19 pandemic has forced States to take restrictive measures to contain the growing number of infections. Among these measures, after the approval of vaccines by the EMA, the possibility of introducing a compulsory vaccination has become a plausible and attractive prospect. In Italy, Covid-19 compulsory vaccination is implemented by a succession of Decrees concerning specific categories of workers and, only recently, a section of the population with the recent Decree of 7 January, 2022, no. 1. However, if we look back at the most critical restrictions implemented in the country, we realise that a de facto obligation was already in place before establishing a de jure obligation. The following article traces the most important profiles of the vaccination obligation implemented de jure and de facto by the Italian government.
新冠肺炎疫情的爆发迫使各国采取限制措施,以遏制不断增长的感染人数。在这些措施中,在欧洲药品管理局批准疫苗后,引入强制性疫苗接种的可能性已成为一个合理且有吸引力的前景。在意大利,新冠肺炎强制疫苗接种是通过一系列关于特定类别工人的法令实施的,直到最近,才通过最近的2022年1月7日第1号法令对一部分人口实施的。然而,如果我们回顾一下该国实施的最关键的限制,我们会意识到,在确立法律义务之前,事实上的义务已经到位。以下文章追溯了意大利政府在法律上和事实上实施的疫苗接种义务的最重要概况。
{"title":"De Jure and De Facto: An Overview on the Italian Measures on Compulsory Vaccination.","authors":"Sofia Palmieri, T. Goffin","doi":"10.1163/15718093-bja10067","DOIUrl":"https://doi.org/10.1163/15718093-bja10067","url":null,"abstract":"The outbreak of the Covid-19 pandemic has forced States to take restrictive measures to contain the growing number of infections. Among these measures, after the approval of vaccines by the EMA, the possibility of introducing a compulsory vaccination has become a plausible and attractive prospect. In Italy, Covid-19 compulsory vaccination is implemented by a succession of Decrees concerning specific categories of workers and, only recently, a section of the population with the recent Decree of 7 January, 2022, no. 1. However, if we look back at the most critical restrictions implemented in the country, we realise that a de facto obligation was already in place before establishing a de jure obligation. The following article traces the most important profiles of the vaccination obligation implemented de jure and de facto by the Italian government.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 1 1","pages":"151-164"},"PeriodicalIF":0.8,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48789780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Legal vs. Extra-Legal Responses to Public Health Emergencies. 对突发公共卫生事件的法律应对与法外应对。
IF 0.8 Q2 LAW Pub Date : 2022-03-01 DOI: 10.1163/15718093-bja10066
C. Günther
There is a long-established claim that emergency action through the law is impossible, or bound to be ineffective. This article seeks to challenge this position by reference to the response of many European states to the Coronavirus pandemic and by drawing on Lon Fuller's theory of law. It argues that there are a number of reasons why a fragmentation of governance between ordinary, legal action and emergency, extra-legal action is neither necessary nor desirable in this specific context. In societies that are generally rule of law compliant governance according to formal legal principles is not only constraining, it also possesses the quality of a 'liberating limitation', creating the room for effective, sustainable action. Too little has been made of this positive dimension of the legal form as an instrument for emergency action.
有一种由来已久的主张认为,通过法律采取紧急行动是不可能的,或者注定是无效的。本文试图通过参考许多欧洲国家对冠状病毒大流行的反应并借鉴朗·富勒的法律理论来挑战这一立场。它认为,在这种具体情况下,有若干原因可以说明,在普通的法律行动和紧急的法外行动之间的治理分割既无必要,也不可取。在普遍遵守法治的社会中,根据正式法律原则进行的治理不仅具有约束性,而且还具有“解放性限制”的性质,为有效、可持续的行动创造了空间。对作为紧急行动工具的法律形式的这一积极方面重视得太少。
{"title":"Legal vs. Extra-Legal Responses to Public Health Emergencies.","authors":"C. Günther","doi":"10.1163/15718093-bja10066","DOIUrl":"https://doi.org/10.1163/15718093-bja10066","url":null,"abstract":"There is a long-established claim that emergency action through the law is impossible, or bound to be ineffective. This article seeks to challenge this position by reference to the response of many European states to the Coronavirus pandemic and by drawing on Lon Fuller's theory of law. It argues that there are a number of reasons why a fragmentation of governance between ordinary, legal action and emergency, extra-legal action is neither necessary nor desirable in this specific context. In societies that are generally rule of law compliant governance according to formal legal principles is not only constraining, it also possesses the quality of a 'liberating limitation', creating the room for effective, sustainable action. Too little has been made of this positive dimension of the legal form as an instrument for emergency action.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 1 1","pages":"131-149"},"PeriodicalIF":0.8,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47255421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Free Movement of Medicines and Protection of Public Health. 药品自由流通和公共卫生保护。
IF 0.8 Q2 LAW Pub Date : 2022-02-28 DOI: 10.1163/15718093-bja10060
Federico Forni
In the Pharma Expressz judgment (case C-178/20) the Court of Justice clarified which conditions a Member State can impose to the import of a medicinal product not having a marketing authorisation in the national territory. The Court pointed out that a medicine not authorised in a Member State can entry in that Member State only in accordance with Article 5(1) of Directive 2001/83/EC on medicinal products for human use. Moreover, according to the Court a national measure requiring a medical prescription and a declaration from the competent national health authority is justified to protect public health although the product can be dispensed in another Member State without a medical prescription. After an overview on the development of pharmaceutical law in the EU, the contribution analyses this judgment in which the Court balanced the Treaty rules on the free movement of goods with the need to protect human health.
在Pharma Expressz的判决(C-178/20号案件)中,法院澄清了成员国可以对在国家领土上没有上市许可的药品进口施加哪些条件。法院指出,未经成员国授权的药物只能根据2001/83/EC号指令关于人类使用的药品的第5(1)条进入该成员国。此外,法院认为,尽管该产品可以在没有处方的情况下在另一个成员国分发,但要求国家卫生主管部门开具处方和声明的国家措施是保护公众健康的正当理由。在概述了欧盟制药法的发展之后,本文分析了这一判决,法院在该判决中平衡了《条约》关于货物自由流动的规则与保护人类健康的必要性。
{"title":"Free Movement of Medicines and Protection of Public Health.","authors":"Federico Forni","doi":"10.1163/15718093-bja10060","DOIUrl":"https://doi.org/10.1163/15718093-bja10060","url":null,"abstract":"In the Pharma Expressz judgment (case C-178/20) the Court of Justice clarified which conditions a Member State can impose to the import of a medicinal product not having a marketing authorisation in the national territory. The Court pointed out that a medicine not authorised in a Member State can entry in that Member State only in accordance with Article 5(1) of Directive 2001/83/EC on medicinal products for human use. Moreover, according to the Court a national measure requiring a medical prescription and a declaration from the competent national health authority is justified to protect public health although the product can be dispensed in another Member State without a medical prescription. After an overview on the development of pharmaceutical law in the EU, the contribution analyses this judgment in which the Court balanced the Treaty rules on the free movement of goods with the need to protect human health.","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"1 1","pages":"1-23"},"PeriodicalIF":0.8,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46928534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Von der Pflicht: Eine Betrachtung, written by Richard David Precht. 冯?德?普夫利奇特:理查德·戴维·普雷希特著。
IF 0.8 Q2 LAW Pub Date : 2022-02-22 DOI: 10.1163/15718093-bja10068
Markus Frischhut
{"title":"Von der Pflicht: Eine Betrachtung, written by Richard David Precht.","authors":"Markus Frischhut","doi":"10.1163/15718093-bja10068","DOIUrl":"https://doi.org/10.1163/15718093-bja10068","url":null,"abstract":"","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"1 1","pages":"1-5"},"PeriodicalIF":0.8,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46163541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Legislator Must Take Effective Measures Ensuring that Persons with Disabilities Are Protected in Triage Situations Caused by the Pandemic 立法者必须采取有效措施,确保残疾人在疫情造成的分诊情况下得到保护
IF 0.8 Q2 LAW Pub Date : 2022-01-11 DOI: 10.1163/15718093-12423546
{"title":"The Legislator Must Take Effective Measures Ensuring that Persons with Disabilities Are Protected in Triage Situations Caused by the Pandemic","authors":"","doi":"10.1163/15718093-12423546","DOIUrl":"https://doi.org/10.1163/15718093-12423546","url":null,"abstract":"","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"1 1","pages":""},"PeriodicalIF":0.8,"publicationDate":"2022-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41895376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
European Court of Justice. 欧洲法院。
IF 0.8 Q2 LAW Pub Date : 2021-12-13 DOI: 10.1163/15718093-12423545
Herman Nys
{"title":"European Court of Justice.","authors":"Herman Nys","doi":"10.1163/15718093-12423545","DOIUrl":"https://doi.org/10.1163/15718093-12423545","url":null,"abstract":"","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 2","pages":"296-306"},"PeriodicalIF":0.8,"publicationDate":"2021-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39836603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The NHS in Northern Ireland Post-Brexit: the Legal Position on Product Supply. 英国脱欧后北爱尔兰的NHS:产品供应的法律地位。
IF 0.8 Q2 LAW Pub Date : 2021-11-05 DOI: 10.1163/15718093-bja10058
Hafsa Yusufi, Tamara Hervey, Astrid Bloemink, Annie Cavanagh, Hannah Shaw

The UK left the European Union's single market on 1 January 2021. A Withdrawal Agreement made special provision for Northern Ireland. However, 'grace periods' concerning supply of goods were agreed, delaying full application of the new rules. The Northern Ireland NHS is heavily reliant on supplies from Great Britain. If these supplies are disrupted, the quality of care offered to patients will diminish. This article shows the legal details of applicable law once the 'grace periods', which are currently securing supply, cease to apply. It reveals significant costs and uncertainties associated with supply of products to the NHS in Northern Ireland. The direction of travel, unless something changes, is that new products will reach patients later than in Great Britain, and there is a real possibility that some products become difficult or impossible for the NHS in Northern Ireland to source. The result will be reduced quality of patient care.

英国将于2021年1月1日退出欧盟单一市场。《脱欧协议》对北爱尔兰作出了特别规定。然而,关于货物供应的“宽限期”已达成协议,推迟了新规则的全面实施。北爱尔兰国民保健服务严重依赖英国的供应。如果这些供应中断,向患者提供的护理质量将会下降。本文显示了一旦“宽限期”(目前正在确保供应)停止适用,适用法律的法律细节。它揭示了与向北爱尔兰国民保健服务提供产品相关的重大成本和不确定性。除非有什么变化,否则新产品到达患者手中的时间将晚于英国,而且很有可能北爱尔兰的NHS很难或根本无法采购到一些产品。其结果将是降低病人护理的质量。
{"title":"The NHS in Northern Ireland Post-Brexit: the Legal Position on Product Supply.","authors":"Hafsa Yusufi,&nbsp;Tamara Hervey,&nbsp;Astrid Bloemink,&nbsp;Annie Cavanagh,&nbsp;Hannah Shaw","doi":"10.1163/15718093-bja10058","DOIUrl":"https://doi.org/10.1163/15718093-bja10058","url":null,"abstract":"<p><p>The UK left the European Union's single market on 1 January 2021. A Withdrawal Agreement made special provision for Northern Ireland. However, 'grace periods' concerning supply of goods were agreed, delaying full application of the new rules. The Northern Ireland NHS is heavily reliant on supplies from Great Britain. If these supplies are disrupted, the quality of care offered to patients will diminish. This article shows the legal details of applicable law once the 'grace periods', which are currently securing supply, cease to apply. It reveals significant costs and uncertainties associated with supply of products to the NHS in Northern Ireland. The direction of travel, unless something changes, is that new products will reach patients later than in Great Britain, and there is a real possibility that some products become difficult or impossible for the NHS in Northern Ireland to source. The result will be reduced quality of patient care.</p>","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 2","pages":"165-193"},"PeriodicalIF":0.8,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39595526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-Border Surrogacy Before the European Court of Human Rights: Analysis of Valdís Fjölnisdóttir And Others v Iceland. 欧洲人权法院的跨境代孕:Valdís Fjölnisdóttir等人诉冰岛案分析。
IF 0.8 Q2 LAW Pub Date : 2021-11-04 DOI: 10.1163/15718093-bja10059
Lydia Bracken

The recent case of Valdís Fjölnisdóttir and Others v Iceland adds to the emerging ECtHR jurisprudence on cross-border surrogacy. It reinforces principles established in previous cases and, in doing so, clarifies the scope of the child's rights under Article 8 ECHR, and hence clarifies the scope of the obligations placed on Member States in cases of cross-border surrogacy. At the same time, consideration of Valdís Fjölnisdóttir reveals significant omissions in the approach adopted by the ECtHR as regards consideration of the rights of the child. In this way, aspects of Valdís Fjölnisdóttir confuse, rather than clarify, the scope of the child's Article 8 ECHR rights in cases of cross-border surrogacy. This article examines the Valdís Fjölnisdóttir judgment with a view to identifying emerging principles, as well as contradictions, in the developing body of jurisprudence relating to cross-border surrogacy.

最近的Valdís Fjölnisdóttir和其他人诉冰岛案增加了欧洲人权法院关于跨境代孕的判例。它加强了以前案例中确立的原则,并以此澄清了《欧洲人权公约》第8条规定的儿童权利范围,从而澄清了成员国在跨境代孕案件中所承担的义务范围。同时,对Valdís Fjölnisdóttir的审议表明,欧洲人权委员会在审议儿童权利方面所采取的办法有重大遗漏。通过这种方式,Valdís Fjölnisdóttir的各个方面混淆了,而不是澄清了,儿童在跨境代孕情况下的《欧洲人权公约》第八条权利的范围。本文考察了Valdís Fjölnisdóttir判决,以期在与跨境代孕相关的法学发展中识别新出现的原则以及矛盾。
{"title":"Cross-Border Surrogacy Before the European Court of Human Rights: Analysis of Valdís Fjölnisdóttir And Others v Iceland.","authors":"Lydia Bracken","doi":"10.1163/15718093-bja10059","DOIUrl":"https://doi.org/10.1163/15718093-bja10059","url":null,"abstract":"<p><p>The recent case of Valdís Fjölnisdóttir and Others v Iceland adds to the emerging ECtHR jurisprudence on cross-border surrogacy. It reinforces principles established in previous cases and, in doing so, clarifies the scope of the child's rights under Article 8 ECHR, and hence clarifies the scope of the obligations placed on Member States in cases of cross-border surrogacy. At the same time, consideration of Valdís Fjölnisdóttir reveals significant omissions in the approach adopted by the ECtHR as regards consideration of the rights of the child. In this way, aspects of Valdís Fjölnisdóttir confuse, rather than clarify, the scope of the child's Article 8 ECHR rights in cases of cross-border surrogacy. This article examines the Valdís Fjölnisdóttir judgment with a view to identifying emerging principles, as well as contradictions, in the developing body of jurisprudence relating to cross-border surrogacy.</p>","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":"29 2","pages":"194-216"},"PeriodicalIF":0.8,"publicationDate":"2021-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39593726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Exploratory Study of the Impact of the Medico-Legal Environment on Surgical Practice in Ireland. 医学法律环境对爱尔兰外科实践影响的探索性研究。
IF 0.8 Q2 LAW Pub Date : 2021-10-28 DOI: 10.1163/15718093-bja10056
Mary-Elizabeth Tumelty, Kaitlyn Cinnamond, Ailish Hannigan, Sean Tierney, Eimear Spain

Defensive medicine describes behaviours engaged in by physicians, for the purposes of averting the threat of medical negligence litigation and/or complaints. Defensive practice typically encompasses 'assurance' or 'avoidance' behaviours, or 'positive' or 'negative' defensive medicine. Assurance behaviours include, for example, meticulous notetaking and ordering further clinically unnecessary tests, whereas avoidance behaviours encompass actions such as refusing to engage with a patient perceived to be high-risk. Whilst such practices may be understandable, defensive medicine is problematic for a number of reasons: it may result in a lower standard of patient care, where for example, a patient is exposed to unnecessary risk(s); and it can increase healthcare costs, which in turn limits resources. Drawing on the findings of a survey of surgeons in Ireland, this study investigates the existence of defensive practices, and explores the impact of the civil and regulatory responses to patient safety incidents on surgical practice. Given the increasing emphasis on patient safety and cultivating a "no-blame" culture both nationally and internationally, the findings of this research illustrate the tension between the current medico-legal and regulatory environment and medical practice, with implications for quality and safety.

防御性医疗描述的是医生为避免医疗过失诉讼和/或投诉威胁而采取的行为。防御性实践通常包括 "保证 "或 "避免 "行为,或 "积极 "或 "消极 "防御性医疗。保证 "行为包括一丝不苟地记笔记和开具更多临床上不必要的检查单等,而 "回避 "行为则包括拒绝接受被视为高风险的病人等。虽然这种做法可以理解,但防御性医疗存在问题的原因有很多:它可能导致患者护理水平降低,例如,患者面临不必要的风险;它可能增加医疗成本,进而限制资源。根据对爱尔兰外科医生的调查结果,本研究调查了防御性做法的存在情况,并探讨了针对患者安全事故的民事和监管对策对外科实践的影响。鉴于国内和国际都越来越重视患者安全和培养 "无责 "文化,本研究的结果说明了当前医疗法律和监管环境与医疗实践之间的紧张关系,并对质量和安全产生了影响。
{"title":"An Exploratory Study of the Impact of the Medico-Legal Environment on Surgical Practice in Ireland.","authors":"Mary-Elizabeth Tumelty, Kaitlyn Cinnamond, Ailish Hannigan, Sean Tierney, Eimear Spain","doi":"10.1163/15718093-bja10056","DOIUrl":"10.1163/15718093-bja10056","url":null,"abstract":"<p><p>Defensive medicine describes behaviours engaged in by physicians, for the purposes of averting the threat of medical negligence litigation and/or complaints. Defensive practice typically encompasses 'assurance' or 'avoidance' behaviours, or 'positive' or 'negative' defensive medicine. Assurance behaviours include, for example, meticulous notetaking and ordering further clinically unnecessary tests, whereas avoidance behaviours encompass actions such as refusing to engage with a patient perceived to be high-risk. Whilst such practices may be understandable, defensive medicine is problematic for a number of reasons: it may result in a lower standard of patient care, where for example, a patient is exposed to unnecessary risk(s); and it can increase healthcare costs, which in turn limits resources. Drawing on the findings of a survey of surgeons in Ireland, this study investigates the existence of defensive practices, and explores the impact of the civil and regulatory responses to patient safety incidents on surgical practice. Given the increasing emphasis on patient safety and cultivating a \"no-blame\" culture both nationally and internationally, the findings of this research illustrate the tension between the current medico-legal and regulatory environment and medical practice, with implications for quality and safety.</p>","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":" ","pages":"1-18"},"PeriodicalIF":0.8,"publicationDate":"2021-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39663055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Azerbaijan's Healthcare Legislation: Major Developments Amid the COVID-19 Pandemic. 阿塞拜疆的医疗保健立法:在 COVID-19 大流行中的重大发展。
IF 0.8 Q2 LAW Pub Date : 2021-10-22 DOI: 10.1163/15718093-bja10057
Lala A Jafarova, Vugar G Mammadov, Leyli E Mammadova

Significant changes in the field of Azerbaijan's healthcare legislation came just at the time when the coronavirus (COVID-19) pandemic broke out in the world. The end of 2019 was supposed to lay the groundwork for the introduction of the country's long-awaited health insurance - a landmark change in terms of national healthcare transformation; although the Law 'On health insurance' was adopted in the 1990s, its implementation was per se frozen for many years due to various reasons. Therefore, the pandemic complicated the process even more. It also coincided with significant updates of the Law 'On human organs and tissues donation and transplantation', which comes into force in 2022, and legislation related to disability. Thus, this paper focuses on recent changes in healthcare legislation; analyses system of health insurance, updated transplantation and disability laws. It gives an overview of the developments that accompany the process of legislation transformation.

就在冠状病毒(COVID-19)大流行在全球爆发之际,阿塞拜疆医疗立法领域发生了重大变化。虽然《医疗保险法》早在 20 世纪 90 年代就已通过,但由于种种原因,该法的实施被冻结多年。因此,大流行病使这一进程变得更加复杂。与此同时,2022 年生效的《人体器官和组织捐献与移植法》以及与残疾有关的立法也进行了重大更新。因此,本文重点关注医疗保健立法的最新变化;分析医疗保险制度、更新的移植和残疾法律。本文概述了伴随立法变革进程的发展情况。
{"title":"Azerbaijan's Healthcare Legislation: Major Developments Amid the COVID-19 Pandemic.","authors":"Lala A Jafarova, Vugar G Mammadov, Leyli E Mammadova","doi":"10.1163/15718093-bja10057","DOIUrl":"10.1163/15718093-bja10057","url":null,"abstract":"<p><p>Significant changes in the field of Azerbaijan's healthcare legislation came just at the time when the coronavirus (COVID-19) pandemic broke out in the world. The end of 2019 was supposed to lay the groundwork for the introduction of the country's long-awaited health insurance - a landmark change in terms of national healthcare transformation; although the Law 'On health insurance' was adopted in the 1990s, its implementation was per se frozen for many years due to various reasons. Therefore, the pandemic complicated the process even more. It also coincided with significant updates of the Law 'On human organs and tissues donation and transplantation', which comes into force in 2022, and legislation related to disability. Thus, this paper focuses on recent changes in healthcare legislation; analyses system of health insurance, updated transplantation and disability laws. It gives an overview of the developments that accompany the process of legislation transformation.</p>","PeriodicalId":43934,"journal":{"name":"EUROPEAN JOURNAL OF HEALTH LAW","volume":" ","pages":"1-18"},"PeriodicalIF":0.8,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39566578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
EUROPEAN JOURNAL OF HEALTH LAW
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1